In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Unmet needs in treatment of acute cardiovascular diseases

Help us improve patient management and outcomes!

Acute Coronary Syndromes (ACS)

Practitioners managing patients with acute cardiovascular diseases continue to face difficulties in bedside clinical decision-making for these patients. Despite major advances in the field, we are still confronted with clinical and logistical difficulties in the management of high risk patients with important variations in the quality of care among different centres, regions and countries. Also significant post-discharge mortality in patients with acute coronary syndromes and other acute cardiovascular syndromes persists. 

The Acute Cardiovascular Care Association wishes to develop a Decision-Making Toolkitto help practitioners make the best bedside clinical decisions when managing these patients.

Your input is key - Tell us how ACS management is organised in your country?

This toolkit must meet your needs, so we are calling on your experience to identify unmet needs and reduce inequities and variations in acute cardiovascular quality care across Europe.

Please watch the video and tell us how ACS management is organised in your country by completing our survey.

The awareness campaign on unmet needs in the field of ACS is supported by an unrestricted educational grant from  

Members of National Working Groups on ACC talk about unmet needs in their countries

The ACCA Toolkit is supported by AstraZeneca and Novartis in the form of an unrestricted educational grant.
These interviews were recorded during the European Summit on Unmet Needs in Acute Cardiovascular Care at the European Heart House, Sophia Antipolis on 22 – 23 April  2013. This Summit was supported with an unrestricted educational grant from AstraZeneca.